sharon sanders
Editor-in-Chief & President
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD style="PADDING-RIGHT: 5px" vAlign=top>Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science
A Hospital-Based Strategy For Setting Priorities For Antiviral Prophylaxis During an Influenza Pandemic
<HR>To cite this paper:
Edbert B. Hsu, Michael G. Millin. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. June 1, 2008, 6(2): 171-178. doi:10.1089/bsp.2007.0057.
<HR><!-- End title of page and review -->Full Text PDF: • HiRes for printing (227.5 KB) • PDF Plus w/ links (230.2 KB)
<!-- Start full text content --><!-- abstract content -->
Edbert B. Hsu Department of Emergency Medicine, Johns Hopkins University, Baltimore, Maryland.
Michael G. Millin Department of Emergency Medicine, Johns Hopkins University, Baltimore, Maryland.
In the event of an influenza pandemic, it is likely that there will be a shortage of antiviral medications to treat flu patients. How will hospitals decide who will receive the available medications? Based on the recommendations of an expert panel, the authors suggest some ways for hospitals to set priorities.
<!-- /abstract content --><!-- fulltext content --><!-- /fulltext content -->
</TD><TD vAlign=top align=right width=170><!-- Previous and Next Articles --><TABLE style="BORDER-BOTTOM: rgb(255,255,255) 2px solid" cellSpacing=0 cellPadding=0 summary=layout border=0><TBODY><TR><TD style="BORDER-BOTTOM: rgb(255,255,255) 1px solid" colSpan=2>http://www.liebertonline.com/toc/bsp/2008/6/2</TD></TR><TR><TD>http://www.liebertonline.com/doi/abs/10.1089/bsp.2007.0056</TD><TD align=right>http://www.liebertonline.com/doi/abs/10.1089/bsp.2007.0054</TD></TR></TBODY></TABLE><!-- side region --></TD></TR></TBODY></TABLE>
<HR width="100%" noShade SIZE=1>
A Hospital-Based Strategy For Setting Priorities For Antiviral Prophylaxis During an Influenza Pandemic
<HR>To cite this paper:
Edbert B. Hsu, Michael G. Millin. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. June 1, 2008, 6(2): 171-178. doi:10.1089/bsp.2007.0057.
<HR><!-- End title of page and review -->Full Text PDF: • HiRes for printing (227.5 KB) • PDF Plus w/ links (230.2 KB)
<!-- Start full text content --><!-- abstract content -->
Edbert B. Hsu Department of Emergency Medicine, Johns Hopkins University, Baltimore, Maryland.
Michael G. Millin Department of Emergency Medicine, Johns Hopkins University, Baltimore, Maryland.
In the event of an influenza pandemic, it is likely that there will be a shortage of antiviral medications to treat flu patients. How will hospitals decide who will receive the available medications? Based on the recommendations of an expert panel, the authors suggest some ways for hospitals to set priorities.
<!-- /abstract content --><!-- fulltext content --><!-- /fulltext content -->
</TD><TD vAlign=top align=right width=170><!-- Previous and Next Articles --><TABLE style="BORDER-BOTTOM: rgb(255,255,255) 2px solid" cellSpacing=0 cellPadding=0 summary=layout border=0><TBODY><TR><TD style="BORDER-BOTTOM: rgb(255,255,255) 1px solid" colSpan=2>http://www.liebertonline.com/toc/bsp/2008/6/2</TD></TR><TR><TD>http://www.liebertonline.com/doi/abs/10.1089/bsp.2007.0056</TD><TD align=right>http://www.liebertonline.com/doi/abs/10.1089/bsp.2007.0054</TD></TR></TBODY></TABLE><!-- side region --></TD></TR></TBODY></TABLE>
<HR width="100%" noShade SIZE=1>